John Wilding, professor of medicine in the Department of Cardiovascular and Metabolic Medicine at the University of Liverpool, said this was unsurprising, adding: Obesity is a chronic disease that usually relapses when treatment is stopped. Tricia Tan, professor of metabolic medicine, diabetes and endocrinology at Imperial College London/Imperial College Healthcare NHS Trust, said: There is increasing evidence that structured exercise is important to prevent weight regain after cessation of weight-loss drugs, but noted that this was not discussed in the study
Growth Hormone Products Amplified effects when combined Increased risk of side effects Requires professional oversight 3
would be interested in taking prescription weight-loss drugs, though interest drops if the drug is not covered by insurance or after hearing patients might gain weight back after stopping use
When paired with GLP-1 treatments, it helps refine body contours, enhance tone, and maintain long-term results
Rotating injection sites helps prevent them
The EMA does not list kidney damage as a common side effect, but its guidance is similar to the FDAs: pay close attention to hydration and kidney function during tirzepatide treatment
